Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$191.17 - $325.63 $5.39 Million - $9.19 Million
-28,212 Reduced 73.57%
10,135 $3.3 Million
Q4 2023

Feb 09, 2024

BUY
$160.99 - $215.69 $103,355 - $138,472
642 Added 1.7%
38,347 $7.31 Million
Q3 2023

Nov 08, 2023

BUY
$194.33 - $283.97 $134,087 - $195,939
690 Added 1.86%
37,705 $7.51 Million
Q2 2023

Aug 11, 2023

BUY
$223.05 - $302.68 $6 Million - $8.14 Million
26,880 Added 265.22%
37,015 $10.6 Million
Q1 2023

Jun 14, 2023

SELL
$175.41 - $217.92 $131,557 - $163,440
-750 Reduced 6.89%
10,135 $2.2 Million
Q1 2023

May 11, 2023

SELL
$175.41 - $217.92 $131,557 - $163,440
-750 Reduced 6.89%
10,135 $2.2 Million
Q4 2022

Jun 14, 2023

BUY
$204.38 - $296.82 $153,285 - $222,615
750 Added 7.4%
10,885 $2.24 Million
Q4 2022

Feb 07, 2023

SELL
$204.38 - $296.82 $73,576 - $106,855
-360 Reduced 3.2%
10,885 $2.24 Million
Q3 2022

Nov 08, 2022

SELL
$195.21 - $310.53 $50,754 - $80,737
-260 Reduced 2.26%
11,245 $3.13 Million
Q2 2022

Aug 05, 2022

SELL
$115.91 - $214.48 $19,704 - $36,461
-170 Reduced 1.46%
11,505 $2.2 Million
Q4 2021

Feb 08, 2022

SELL
$165.13 - $241.83 $3,797 - $5,562
-23 Reduced 0.2%
11,675 $2.08 Million
Q3 2021

Nov 08, 2021

BUY
$163.99 - $235.57 $59,036 - $84,805
360 Added 3.18%
11,698 $2.41 Million
Q2 2021

Aug 10, 2021

BUY
$131.45 - $201.49 $194,283 - $297,802
1,478 Added 14.99%
11,338 $2.15 Million
Q1 2021

May 10, 2021

BUY
$92.73 - $142.05 $42,655 - $65,343
460 Added 4.89%
9,860 $1.28 Million
Q4 2020

Feb 08, 2021

BUY
$67.44 - $103.72 $65,416 - $100,608
970 Added 11.51%
9,400 $975,000
Q3 2020

Nov 09, 2020

BUY
$42.79 - $75.8 $30,380 - $53,818
710 Added 9.2%
8,430 $639,000
Q2 2020

Aug 07, 2020

BUY
$27.25 - $47.53 $210,370 - $366,931
7,720 New
7,720 $366,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.